Floatz logo

Glipizide

Obesity and Type 2 Diabetes

Washington University School of MedicineSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Obesity and Type 2 Diabetes cohort.

Asset / SponsorPhaseRating
Enavogliflozin
Korea University Anam Hospital
Phase 4BB
nt-0796
NodThera Limited
Phase 2B
Ibipinabant
Solvay Pharmaceuticals
Phase 2/3CCC
Trigonella Foenum-Graecum Seed Extract
University of Hail
N/AD

Same molecule, other indications

Glipizide is also rated in:

diabetes mellitusDormant
B
Indicative ·
62 / 100
View asset →
exocrine pancreatic carcinomaDormant
CCC
Indicative ·
53 / 100
View asset →
malignant pancreatic neoplasmDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →